CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients

Napolitano, S; Martini, G; Ciardiello, D; Di Maio, M; Normanno, N; Avallone, A; Martinelli, E; Maiello, E; Troiani, T; Ciardiello, F

Napolitano, S (通讯作者)，Univ Campania L Vanvitelli, Dipartimento Med Precis, Oncol Med, Naples, Italy.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

Introduction: Immunotherapy has limited efficacy in metastatic colorectal cancer (mCRC). Understanding mechanisms mediating immune resistance in micro......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索